Determinants of antidepressant response: Implications for practice and future clinical trials
Background: Response to antidepressants in major depressive disorder is variable and determinants are not well understood or used to design clinical trials. We aimed to understand these determinants. Methods: Supported by Innovative Medicines Initiative, as part of a large public-private collaborati...
Main Authors: | Kapur, S. (Author), Mandel, F.S (Author), Marangell, L. (Author), Menard, F. (Author), Rabinowitz, J. (Author), Werbeloff, N. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier B.V.
2018
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Remote Digital Measurement of Facial and Vocal Markers of Major Depressive Disorder Severity and Treatment Response: A Pilot Study
by: Anzar Abbas, et al.
Published: (2021-03-01) -
Validity and test–retest reliability of the Persian version of the Montgomery–Asberg Depression Rating Scale
by: Ahmadpanah M, et al.
Published: (2016-03-01) -
Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression
by: Banasr, M., et al.
Published: (2018) -
Re-evaluation of Significance and the Implications of Placebo Effect in Antidepressant Therapy
by: Marko Curkovic, et al.
Published: (2019-03-01) -
Fluoxetine in the Management of Major Depressive Disorder in Children and Adolescents: A Meta-Analysis of Randomized Controlled Trials
by: Girgis, E., et al.
Published: (2021)